Mark Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk’s Parkinson’s cell therapy

Meta CEO Mark Zuckerberg backed-Cellular Intelligence has acquired Danish drugmaker Novo Nordisk’s cell therapy candidate for Parkinson’s disease, the biotech firm said on Monday.

Last October, Novo Nordisk had shut down its cell therapy unit as part of a broader restructuring, discontinuing development ‌of ⁠the therapy.